EXHIBIT 10.36 *** TEXT OMITTED AND FILED SEPARATELY CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS.200.80(B)(4), 200.83 AND 240.24B-2Technology Development and Services Agreement • August 12th, 1998 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products
